ABSTRACT
Introduction: Blau syndrome (BS) is a rare autoimmune disease. We report here an atypical case of BS. Case Presentation: We present a case of late-onset eye manifestations in a Chinese girl of 18 years old with sporadic BS, presenting with panuveitis. We performed comprehensive ocular examinations including fluorescein fundus angiography and indocyanine green angiography for her. The oral hormone plus local anti-inflammatory eye drops have well controlled the inflammation of her eyes. Conclusion: Our case highlights the necessity of systemic medical history inquiry for every eye discomfort.
ABSTRACT
Objective: Investigate the Correlation Between the Severity of Coronary Artery Disease and Retinal Artery Disease, and assess the Efficacy of Angiotensin-Converting Enzyme Inhibitors (ACEIs) Application. Methods: One hundred patients diagnosed with primary hypertension at our hospital were chosen for the study. All patients underwent dual-source 64-layer spiral CT coronary angiography and fundus photography examination. Based on the extent of coronary artery stenosis, the patients were divided into Group A, Group B, Group C, and Group D. Results: In comparison with patients in Group A, individuals in Groups B, C, and D exhibited a notable increase in the severity of retinal artery stenosis and arteriovenous crossing signs (P < .05). Furthermore, the severity of retinal artery stenosis and arteriovenous crossing signs demonstrated an incremental trend with the severity of coronary artery stenosis (P < .05). The arteriovenous crossing sign exhibited a sensitivity of 47.87%, the specificity of 89.21%, positive predictive value of 89.76%, and the negative predictive value of 46.53% for predicting coronary artery stenosis. After treatment, the blood pressure levels of the patients, both systolic (SBP) and diastolic blood pressure (DBP) levels significantly decreased compared to before treatment. Conclusion: A significant positive correlation was observed between the severity of coronary artery lesions and retinal artery lesions. Assessing alterations in retinal blood vessels in hypertensive patients can effectively indicate the extent of coronary artery stenosis indirectly. Concerning medication, the antihypertensive drug captopril demonstrated the potential to alleviate the severity of coronary artery and retinal artery lesions in hypertensive patients. However, specific treatment methods should be tailored to individual patient circumstances.
ABSTRACT
RATIONALE: Branch retinal artery occlusion (BRAO) is a rare complication of retinal arterial macroaneurysm (RAM), a low-incidence ocular disease. PATIENT CONCERNS: A 75-year-old woman presented with a chief complaint of blurred vision. DIAGNOSES: The patient for 4 days received a diagnosis of RAM combined with BRAO. INTERVENTIONS: The patient was treated with two successive intravitreal conbercept injections. OUTCOMES: The patient's best-corrected visual acuity improved, and the RAM diminished. LESSONS: Administration of conbercept injection might be an effective treatment for complex RAM with BRAO.
Subject(s)
Retinal Arterial Macroaneurysm , Retinal Artery Occlusion , Female , Humans , Aged , Angiogenesis Inhibitors/therapeutic use , Retinal Arterial Macroaneurysm/complications , Retinal Arterial Macroaneurysm/drug therapy , Retinal Artery Occlusion/complications , Retinal Artery Occlusion/drug therapy , Recombinant Fusion Proteins , Intravitreal InjectionsABSTRACT
While adiponectin (APN) was known to significantly abolish the diabetic endothelial inflammatory response, the specific mechanisms have yet to be elucidated. Aortic vascular tissues from mice fed normal and high-fat diets (HFD) were analyzed by transcriptome analysis. GO functional annotation showed that APN inhibited vascular endothelial inflammation in an APPL1-dependent manner. We confirmed that activation of the Wnt/ß-catenin signaling plays a key role in APN-mediated anti-inflammation. Mechanistically, APN promoted APPL1/reptin complex formation and ß-catenin nuclear translocation. Simultaneously, we identified APN promoted the expression of CD44 by activating TCF/LEF in an APPL1-mediated manner. Clinically, the serum levels of APN and CD44 were decreased in diabetes; the levels of these two proteins were positively correlated. Functionally, treatment with CD44 C-terminal polypeptides protected diabetes-induced vascular endothelial inflammation in vivo. Collectively, we provided a roadmap for APN-inhibited vascular inflammatory effects and CD44 might represent potential targets against the diabetic endothelial inflammatory effect.
ABSTRACT
The injury of vascular endothelial cells is a crucial factor in the development of diabetic retinopathy (DR). PDLIM1 (a member of the PDZ and LIM protein family) has been reported to exert an essential function in vascular diseases. This study aimed to elucidate the role of PDLIM1 on retinal vascular endothelial cells in DR. Immunofluorescence staining was used to localize the expression of PDLIM1 in the mouse retina. In some tumor diseases, PDLIM1 has been reported to play a key role in regulating the Wnt pathway. However, no in-depth reports have been found in DR. Retinal capillary endothelial cells (RCECs) were treated with high-glucose and high-lipid (HG/HL) culture medium, and siRNA transfection to investigate the role of PDLIM1 in DR. PDLIM1 and Wnt3a expression was confirmed by qRT-PCR and western blotting. Flow cytometry, Transwell assay, and scratch assay were used to test the ability of cell apoptosis, migration, and invasion. PDLIM1 was mainly expressed in the retinal pigment epithelium (RPE), ganglion cell layer (GCL), inner plexus layer (IPL), and outer plexus layer (OPL). HG/HL increased Wnt3a levels and promoted cell's ability of apoptosis, migration, and invasion, which were reversed by the knockdown of PDLIM1. PDLIM1 was found to play a protective role in diabetic retinopathy by counter-regulating Wnt3a. PDLIM1 ameliorates cell apoptosis, migration, and invasion by negatively regulating Wnt3a in RCECs of DR, which suggests that PDLIM1 might be a promising therapeutic target for DR treatment.
Subject(s)
Diabetes Mellitus , Diabetic Retinopathy , LIM Domain Proteins , Wnt3A Protein , Animals , Mice , Cell Movement , Diabetes Mellitus/metabolism , Diabetic Retinopathy/pathology , Endothelial Cells/metabolism , Neoplastic Processes , Retina/pathology , LIM Domain Proteins/genetics , Wnt3A Protein/geneticsABSTRACT
This article reports a case of macular hole (MH) formation following intravitreal conbercept injection for branch retinal vein occlusion (BRVO). A 70-year-old male received three consecutive intravitreal injections of conbercept for the treatment of macular edema secondary to BRVO in his left eye. Due to the outbreak of the COVID-19 epidemic, the patient was lost to follow-up. At two months follow-up, a full-thickness MH was detected by fundoscopic and optical coherence tomography examination. Fortunately, the MH was successfully closed after pars plana vitrectomy. MH is a rare complication following intravitreal injections for RVO, which should be considered by clinicians.
ABSTRACT
Objective. Optical coherence tomography (OCT) has become an essential imaging modality for the assessment of ophthalmic diseases. However, speckle noise in OCT images obscures subtle but important morphological details and hampers its clinical applications. In this work, a novel multi-task generative adversarial network (MGAN) is proposed for retinal OCT image denoising.Approach. To strengthen the preservation of retinal structural information in the OCT denoising procedure, the proposed MGAN integrates adversarial learning and multi-task learning. Specifically, the generator of MGAN simultaneously undertakes two tasks, including the denoising task and the segmentation task. The segmentation task aims at the generation of the retinal segmentation map, which can guide the denoising task to focus on the retina-related region based on the retina-attention module. In doing so, the denoising task can enhance the attention to the retinal region and subsequently protect the structural detail based on the supervision of the structural similarity index measure loss.Main results. The proposed MGAN was evaluated and analyzed on three public OCT datasets. The qualitative and quantitative comparisons show that the MGAN method can achieve higher image quality, and is more effective in both speckle noise reduction and structural information preservation than previous denoising methods.Significance. We have presented a MGAN for retinal OCT image denoising. The proposed method provides an effective way to strengthen the preservation of structural information while suppressing speckle noise, and can promote the OCT applications in the clinical observation and diagnosis of retinopathy.
Subject(s)
Algorithms , Tomography, Optical Coherence , Tomography, Optical Coherence/methods , Image Processing, Computer-Assisted/methods , Retina/diagnostic imaging , Retina/anatomy & histologyABSTRACT
BACKGROUND: the Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) dementia risk score is a recognised tool for dementia risk stratification. However, its application is limited due to the requirements for multidimensional information and fasting blood draw. Consequently, an effective and non-invasive tool for screening individuals with high dementia risk in large population-based settings is urgently needed. METHODS: a deep learning algorithm based on fundus photographs for estimating the CAIDE dementia risk score was developed and internally validated by a medical check-up dataset included 271,864 participants in 19 province-level administrative regions of China, and externally validated based on an independent dataset included 20,690 check-up participants in Beijing. The performance for identifying individuals with high dementia risk (CAIDE dementia risk score ≥ 10 points) was evaluated by area under the receiver operating curve (AUC) with 95% confidence interval (CI). RESULTS: the algorithm achieved an AUC of 0.944 (95% CI: 0.939-0.950) in the internal validation group and 0.926 (95% CI: 0.913-0.939) in the external group, respectively. Besides, the estimated CAIDE dementia risk score derived from the algorithm was significantly associated with both comprehensive cognitive function and specific cognitive domains. CONCLUSIONS: this algorithm trained via fundus photographs could well identify individuals with high dementia risk in a population setting. Therefore, it has the potential to be utilised as a non-invasive and more expedient method for dementia risk stratification. It might also be adopted in dementia clinical trials, incorporated as inclusion criteria to efficiently select eligible participants.
Subject(s)
Deep Learning , Dementia , Humans , Dementia/diagnosis , Dementia/epidemiology , Dementia/psychology , Aging/psychology , Risk Factors , CognitionABSTRACT
Automatic and accurate optical coherence tomography (OCT) image classification is of great significance to computer-assisted diagnosis of retinal disease. In this study, we propose a hybrid ConvNet-Transformer network (HCTNet) and verify the feasibility of a Transformer-based method for retinal OCT image classification. The HCTNet first utilizes a low-level feature extraction module based on the residual dense block to generate low-level features for facilitating the network training. Then, two parallel branches of the Transformer and the ConvNet are designed to exploit the global and local context of the OCT images. Finally, a feature fusion module based on an adaptive re-weighting mechanism is employed to combine the extracted global and local features for predicting the category of OCT images in the testing datasets. The HCTNet combines the advantage of the convolutional neural network in extracting local features and the advantage of the vision Transformer in establishing long-range dependencies. A verification on two public retinal OCT datasets shows that our HCTNet method achieves an overall accuracy of 91.56% and 86.18%, respectively, outperforming the pure ViT and several ConvNet-based classification methods.
Subject(s)
Neural Networks, Computer , Tomography, Optical Coherence , Retina/diagnostic imagingABSTRACT
PURPOSE: There are primarily two techniques for affixing the scleral buckle (SB) to the sclera in the repair of rhegmatogenous retinal detachment (RRD): scleral tunnels or scleral sutures. METHODS: This retrospective study examined all patients with primary RRD who were treated with primary SB or SB combined with vitrectomy from January 1, 2015 through December 31, 2015 across six sites. Two cohorts were examined: SB affixed using scleral sutures versus scleral tunnels. Pre- and postoperative variables were evaluated including visual acuity, anatomic success, and postoperative strabismus. RESULTS: The mean preoperative logMAR VA for the belt loop cohort was 1.05 ± 1.06 (Snellen 20/224) and for the scleral suture cohort was 1.03 ± 1.04 (Snellen 20/214, p = 0.846). The respective mean postoperative logMAR VAs were 0.45 ± 0.55 (Snellen 20/56) and 0.46 ± 0.59 (Snellen 20/58, p = 0.574). The single surgery success rate for the tunnel cohort was 87.3% versus 88.6% for the suture cohort (p = 0.601). Three patients (1.0%) in the scleral tunnel cohort developed postoperative strabismus, but only one patient (0.1%) in the suture cohort (p = 0.04, multivariate p = 0.76). All cases of strabismus occurred in eyes that underwent SB combined with PPV (p = 0.02). There were no differences in vision, anatomic success, or strabismus between scleral tunnels versus scleral sutures in eyes that underwent primary SB. CONCLUSION: Scleral tunnels and scleral sutures had similar postoperative outcomes. Combined PPV/SB in eyes with scleral tunnels might be a risk for strabismus post retinal detachment surgery.
ABSTRACT
OBJECTIVE: Accumulating evidence suggests the critical role of autophagy in the pathogenesis of diabetic retinopathy (DR). In the current study, we aim to identify autophagy genes involved in DR via microarray analyses. METHODS: Gene microarrays were performed to identify differentially expressed lncRNAs/mRNAs between normal and DR retinas. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses of lncRNA-coexpressed mRNAs were used to determine the related pathological pathways and biological modules. Real-time polymerase chain reactions (PCR) were conducted to validate the microarray analyses. RESULTS: A total of 2474 significantly dysregulated lncRNAs and 959 differentially expressed mRNAs were identified in the retina of DR. Based upon Signalnet analysis, Bcl2, Gabarapl2, Atg4c, and Atg16L1 participated the process of cell death in DR. Moreover, real-time PCR revealed significant upregulation of Atg16L1. CONCLUSION: This study indicated the importance and potential role of Atg16L1, one of the autophagy genes, as a biomarker in DR development and progression.
Subject(s)
Autophagy-Related Proteins/physiology , Autophagy/genetics , Diabetic Retinopathy/genetics , Animals , Autophagy/physiology , Biomarkers , Diabetic Retinopathy/etiology , Male , Mice , Mice, Inbred C57BL , RNA, Long Noncoding/analysis , RNA, Messenger/analysisABSTRACT
BACKGROUND/AIMS: Vitrectomy to repair retinal detachment is often performed with either non-contact wide-angle viewing systems or wide-angle contact viewing systems. The purpose of this study is to assess whether the viewing system used is associated with any differences in surgical outcomes of vitrectomy for primary non-complex retinal detachment repair. METHODS: This is a multicenter, interventional, retrospective, comparative study. Eyes that underwent non-complex primary retinal detachment repair by either pars plana vitrectomy (PPV) alone or in combination with scleral buckle/PPV in 2015 were evaluated. The viewing system at the time of the retinal detachment repair was identified and preoperative patient characteristics, intraoperative findings and postoperative outcomes were recorded. RESULTS: A total of 2256 eyes were included in our analysis. Of those, 1893 surgeries used a non-contact viewing system, while 363 used a contact lens system. There was no statistically significant difference in single surgery anatomic success at 3 months (p=0.72), or final anatomic success (p=0.40). Average postoperative visual acuity for the contact-based cases was logMAR 0.345 (20/44 Snellen equivalent) compared with 0.475 (20/60 Snellen equivalent) for non-contact (p=0.001). After controlling for numerous confounding variables in multivariable analysis, viewing system choice was no longer statistically significant (p=0.097). CONCLUSION: There was no statistically significant difference in anatomic success achieved for primary retinal detachment repair when comparing non-contact viewing systems to contact lens systems. Postoperative visual acuity was better in the contact-based group but this was not statistically significant when confounding factors were controlled for.
Subject(s)
Contact Lenses , Retinal Detachment/surgery , Scleral Buckling/instrumentation , Surgery, Computer-Assisted/instrumentation , Visual Acuity , Vitrectomy/instrumentation , Equipment Design , Female , Follow-Up Studies , Humans , Male , Middle Aged , Postoperative Period , Retinal Detachment/diagnosis , Retrospective StudiesABSTRACT
PURPOSE: To evaluate topical dorzolamide hydrochloride-timolol maleate as an adjunct therapy to intravitreous anti-vascular endothelial growth factor injections in eyes with retinal vein occlusion resistant to treatment. METHODS: Retinal vein occlusion patients with a history of persistent macular edema, despite fixed-interval intravitreous anti-vascular endothelial growth factor injections, were enrolled between April 4, 2016, and June 4, 2017. On enrollment, patients were instructed to administer one drop of topical dorzolamide-timolol twice daily for the duration of the study. They were maintained on the same anti-vascular endothelial growth factor drug and same interval between injections as preenrollment for the subsequent two visits. Primary outcome measures were change in central foveal thickness, central subfield thickness, and thickest macular cut at the final study visit. RESULTS: Eight patients (8 eyes) were eligible for enrollment and completed the study. There was a significant decrease in central foveal thickness (P = 0.02), central subfield thickness (P = 0.03), and thickest macular cut (P = 0.01) between the enrollment visit and the final visit. There was a decrease in mean (±SD) logarithm of the minimal angle of resolution from 0.52 (±0.35) (20/66, Snellen equivalent) at the enrollment visit to 0.41 (±0.35) (20/51, Snellen equivalent) at the final visit (P = 0.08). CONCLUSION: Topical dorzolamide-timolol may have a beneficial anatomical and functional effect in eyes with macular edema secondary to retinal vein occlusion resistant to treatment.
Subject(s)
Angiogenesis Inhibitors/therapeutic use , Macular Edema/drug therapy , Retinal Vein Occlusion/drug therapy , Sulfonamides/therapeutic use , Thiophenes/therapeutic use , Timolol/therapeutic use , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Administration, Ophthalmic , Aged , Aged, 80 and over , Bevacizumab/therapeutic use , Drug Combinations , Drug Therapy, Combination , Female , Fovea Centralis/pathology , Humans , Intraocular Pressure/physiology , Intravitreal Injections , Macular Edema/diagnostic imaging , Macular Edema/etiology , Male , Middle Aged , Ophthalmic Solutions , Pilot Projects , Ranibizumab/therapeutic use , Receptors, Vascular Endothelial Growth Factor/therapeutic use , Recombinant Fusion Proteins/therapeutic use , Retinal Vein Occlusion/complications , Retinal Vein Occlusion/diagnostic imaging , Tomography, Optical Coherence , Visual Acuity/physiologySubject(s)
Retinal Detachment/surgery , Aged , Basement Membrane/surgery , Female , Humans , Male , Middle Aged , Retrospective Studies , Visual AcuityABSTRACT
BACKGROUND AND OBJECTIVE: Non-causal macular holes (MHs) can occur concurrently with rhegmatogenous retinal detachments (RRDs). The visual outcomes and surgical approach for these eyes are variable. PATIENTS AND METHODS: This was a multi-institutional, retrospective review of all primary retinal detachment surgeries from January 1, 2015, through December 31, 2015. Pre-, intra-, and postoperative metrics were recorded. RESULTS: There were 2,242 eyes that had pars plana vitrectomy for primary RRD, 43 (1.9%) of which had a MH at the time of surgery. The mean postoperative logMAR visual acuity (VA) for the MH cohort was 0.87 ± 0.64 (20/148) and for eyes without a MH was 0.47 ± 0.63 (20/59; P < .0001). The single-surgery re-attachment rate for the MH cohort and no MH cohort was 86.1% and 84.9%, respectively (P = 1.0000). CONCLUSIONS: Patients with noncausal MHs and RRD had significantly worse VA than patients without a MH. Preoperative counseling is imperative in patients with both RRD and MH. [Ophthalmic Surg Lasers Imaging Retina. 2020;51:500-505.].
Subject(s)
Macula Lutea/pathology , Retinal Perforations/diagnosis , Visual Acuity , Vitrectomy/methods , Female , Follow-Up Studies , Humans , Male , Middle Aged , Retinal Perforations/surgery , Retrospective Studies , Treatment OutcomeABSTRACT
A full-thickness macular hole (FTMH) is a rare sequela to submacular hemorrhage. Herein, the authors report a case of an 80-year-old man actively being treated for neovascular age-related macular degeneration who presented with sudden vision loss in the right eye. Examination with optical coherence tomography (OCT) imaging revealed submacular hemorrhage. The patient underwent vitrectomy with subretinal tissue plasminogen activator (tPA) with no intraoperative complications. Dilated fundus examination and OCT imaging revealed a FTMH at postop week 1. Possible causes for MH development include the submacular hemorrhage itself and subretinal administration of the tPA infusion. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:e257-e259.].
Subject(s)
Choroidal Neovascularization/complications , Fibrinolytic Agents/therapeutic use , Injections, Intraocular/adverse effects , Retinal Hemorrhage/drug therapy , Retinal Perforations/etiology , Tissue Plasminogen Activator/therapeutic use , Wet Macular Degeneration/complications , Aged, 80 and over , Endotamponade , Fluorescein Angiography , Humans , Male , Retinal Hemorrhage/diagnostic imaging , Retinal Hemorrhage/etiology , Retinal Perforations/diagnostic imaging , Tomography, Optical Coherence , Visual Acuity , VitrectomyABSTRACT
BACKGROUND AND OBJECTIVE: To determine the efficacy of anti-vascular endothelial growth factor (VEGF) therapy for macular edema due to central retinal vein occlusion (CRVO) in younger adults. PATIENTS AND METHODS: The outcomes of CRVO patients age 40 years or younger with baseline logarithm of the minimum angle of resolution (logMAR) visual acuity (VA) between 1.30 (20/400 Snellen equivalent) and 0.30 (20/40 Snellen equivalent) and central retinal thickness (CRT) greater than 250 µm were reviewed. VA and CRT were measured at baseline and months 1, 3, 6, and 12. RESULTS: Seventeen eyes of 17 young CRVO patients were included in this study. The logMAR VA improved significantly from 0.64 (20/87 Snellen equivalent) to 0.14 (20/28 Snellen equivalent) 12 months following treatments (P < .001). The CRT decreased from 619 µm ± 238 µm at baseline to 290 µm ± 34 µm at 12 months (P < .001). CONCLUSION: Anti-VEGF injections appear to be effective for macular edema regression and vision improvement in younger adults with CRVO over 12 months of follow-up. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:e96-e104.].
Subject(s)
Bevacizumab/administration & dosage , Macula Lutea/diagnostic imaging , Macular Edema/drug therapy , Retinal Vein Occlusion/complications , Visual Acuity , Adolescent , Adult , Angiogenesis Inhibitors/administration & dosage , Female , Follow-Up Studies , Humans , Intravitreal Injections , Macular Edema/diagnosis , Macular Edema/etiology , Male , Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors , Retinal Vein Occlusion/diagnosis , Retinal Vein Occlusion/drug therapy , Retrospective Studies , Tomography, Optical Coherence/methods , Treatment Outcome , Young AdultABSTRACT
PURPOSE: To determine the rate of loss to follow-up (LTFU) and associated risk factors in patients with nonproliferative diabetic retinopathy (NPDR) who had diabetic macular edema (DME) and were receiving intravitreal anti-vascular endothelial growth factor (VEGF) injections. DESIGN: Retrospective cohort study. PARTICIPANTS: A total of 2595 NPDR patients with DME who received at least one anti-VEGF injection at a single large retina practice from January 1, 2012, to January 1, 2017. METHODS: A retrospective review based on billing codes was performed. LTFU was defined as no subsequent office visits within 12 months after an intravitreal injection. Patient demographics and clinical features were evaluated, and logistic regression was used to identify independent predictors for LTFU. MAIN OUTCOME MEASURES: LTFU rates and potential risk factors. RESULTS: LTFU was found in 413 (25.3%) of 1632 patients. Examining LTFU by racial groups, 21.3% identified themselves as white, 29.1% as black, 30.6% as Asian, and 35.0% as Hispanic (P < 0.001). A difference in LTFU was also found based on average adjusted gross income (AGI) (P < 0.001) and NPDR stage (P = 0.04). In the multivariate model, factors associated with LTFU included Hispanic (odds ratio [OR] 1.66), American Indian, Pacific Islander, multiple races (OR 2.60), and unknown race (OR 1.59) compared with those who were white. Additional factors included those with an average AGI of $50000 to $75000 (OR 1.37) and <$50000 (OR 1.88) compared with those with an average AGI > $75000. Based on subgroup analysis of patients with available visual acuity data, a significant association was found between decreasing baseline vision and LTFU (P < 0.001). CONCLUSIONS: Approximately 1 in 4 patients with NPDR who had DME had no follow-up visit for at least 1 year after an anti-VEGF injection. Given the importance of ongoing therapy, these real-world findings may help identify at-risk groups for noncompliance with care.
Subject(s)
Angiogenesis Inhibitors/administration & dosage , Diabetic Retinopathy/drug therapy , Macular Edema/drug therapy , Aged , Aged, 80 and over , Bevacizumab/administration & dosage , Female , Follow-Up Studies , Humans , Intravitreal Injections , Logistic Models , Male , Middle Aged , Ranibizumab/administration & dosage , Retrospective StudiesABSTRACT
BACKGROUND AND OBJECTIVE: This study examines whether pars plana vitrectomy (PPV) can achieve a high rate of reattachment in primary rhegmatogenous retinal detachments (RRDs) caused by inferior breaks in phakic eyes. PATIENTS AND METHODS: Patients with primary, phakic RRD with inferior retinal breaks repaired by PPV, endolaser, and gas tamponade between January 2012 and December 2016 were included. RESULTS: Twenty-six eyes from 26 patients were included. Mean patient age was 61.7 years (range: 38 years to 82 years). Thirteen RRDs were macula-involving, with an average of 2.00 ± 0.70 quadrants and 2.50 ± 2.00 breaks. Twenty-three of 26 eyes (88.5%) were attached at postoperative month (POM) 3. Mean logMAR visual acuity was 0.72 ± 0.84 at baseline, 0.65 ± 0.44 at POM 3, 0.44 ± 0.50 at POM 12, and 0.43 ± 0.36 at the final visit. CONCLUSION: Single-surgery success rate of phakic RRD caused by inferior breaks repaired by PPV is high. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:153-158.].